1. Asano J, Suzuki Y, Yajima S, Inoue K, Shimozawa I, Kondo N, Murase M, Orii T (1994): Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Brain Dev16: 454–458
2. Brown FR, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982): Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J151: 344–361
3. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, Wisniewski HK, Ritch RH, Norton WT, Rapin I, Gartner LM (1973): Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science182: 62–64
4. Igarashi M, Schaumburg HH, Powers J, Kishimoto Y, Kolodney E, Suzuki K (1976): Fatty acid abnormality in adrenoleukodystrophy. J Neurochem26: 851–860
5. Lazarow PB, Moser HW (1995): Disorders, of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2287–2324